Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sabarinathan

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
MMWR. Morbidity and Mortality Weekly Report|September 14, 2018
Sentinel Surveillance for Congenital Rubella Syndrome - India, 2016-2017Manoj Murhekar, Ashish Bavdekar, Asha Benakappa, et al.
IJID Regions|June 20, 2022
SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021Avula Laxmaiah, Nalam Madhusudhan Rao, N Arlappa, et al.
Vaccine|December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20C Prosperi, J W V Thangaraj, A Z Hasan, et al.
The Lancet. Global Health|October 14, 2022
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020Manoj V Murhekar, Nivedita Gupta, Alvira Z Hasan, et al.
The Lancet. Global Health|June 16, 2019
Burden of dengue infection in India, 2017: a cross-sectional population based serosurveyManoj V Murhekar, P Kamaraj, Muthusamy Santhosh Kumar, et al.
PLOS Global Public Health|October 30, 2025
Active case-finding for TB in India: Assessment of scale and quality benchmarks, time taken and use of rapid molecular diagnostic testsHemant Deepak Shewade, S Kiran Pradeep, Prabhadevi Ravichandran, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
Vaccine|July 3, 2024
Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022Devika Shanmugasundaram, Rajlakshmi Viswanathan, Amy K Winter, et al.
Global Health, Science and Practice|April 28, 2023
The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care CascadeHemant Deepak Shewade, Asha Frederick, G Kiruthika, et al.
Global Health Action|January 9, 2023
--Eleven tips for operational researchers working with health programmes: our experience based on implementing differentiated tuberculosis care in south IndiaHemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
MMWR. Morbidity and Mortality Weekly Report|September 14, 2018
Sentinel Surveillance for Congenital Rubella Syndrome - India, 2016-2017Manoj Murhekar, Ashish Bavdekar, Asha Benakappa, et al.
IJID Regions|June 20, 2022
SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021Avula Laxmaiah, Nalam Madhusudhan Rao, N Arlappa, et al.
Vaccine|December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20C Prosperi, J W V Thangaraj, A Z Hasan, et al.
The Lancet. Global Health|October 14, 2022
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020Manoj V Murhekar, Nivedita Gupta, Alvira Z Hasan, et al.
The Lancet. Global Health|June 16, 2019
Burden of dengue infection in India, 2017: a cross-sectional population based serosurveyManoj V Murhekar, P Kamaraj, Muthusamy Santhosh Kumar, et al.
PLOS Global Public Health|October 30, 2025
Active case-finding for TB in India: Assessment of scale and quality benchmarks, time taken and use of rapid molecular diagnostic testsHemant Deepak Shewade, S Kiran Pradeep, Prabhadevi Ravichandran, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
Vaccine|July 3, 2024
Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022Devika Shanmugasundaram, Rajlakshmi Viswanathan, Amy K Winter, et al.
Global Health, Science and Practice|April 28, 2023
The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care CascadeHemant Deepak Shewade, Asha Frederick, G Kiruthika, et al.
Global Health Action|January 9, 2023
--Eleven tips for operational researchers working with health programmes: our experience based on implementing differentiated tuberculosis care in south IndiaHemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, et al.
Pageof 5